Mycoses in hemathological patients;Micosis en los pacientes hematológicos

Revista Iberoamericana de Micologia

Volumn 19, Issue 1, 2002, Pages 13-16

  García Ruiz, Juan Carlos ^a  

^a HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ASPERGILLUS; CANDIDA; DISEASE ASSOCIATION; HEMATOLOGIC DISEASE; HUMAN; INCIDENCE; MYCOSIS; PROPHYLAXIS; RISK FACTOR; SHORT SURVEY;

EID: 0036244833     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (20)

1. Fungal infections in cancer patients: A international autopsy survey
2. Fungal infections found during autopsies: A report from Spain
3. Evolving risk factors for invasive fungal infections All neutropenic patients are not the same
4. Predictors of adverse outcome in cancer patients with candidemia
5. Candidemia in immunocompromised patients
6. Chronic systemic candidiasis in acute leukemia
7. Increase in Candida krusei infections among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole
8. Epidemiology of Aspergillus infection in a large cohort of patients undergoing bone marrow transplantation
9. Postmortem analysis of invasive aspergilosis in a tertiary care hospital
10. Infecciones fúngicas invasivas en pacientes con hemopatias malignas: Una aproximación clínica
11. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
12. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of CDC, the Infection Disease Society of America and the American Society of Blood and Marrow Transplantation
13. NIAID Mycoses Study Group multi-center trial of oral itraconazol therapy of invasive aspergilosis
14. Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukemia
15. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy
16. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: A randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B
17. A ramdomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with hematological malignancies
18. Itraconazole oral solution as antifungal prophylaxis in children undergoing stem cell transplantation or intensive chemotherapy for haematological disorders
19. Aspergilosis broncopulmonar invasiva tratada con itraconazol en una paciente con leucemia aguda